Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical Co

14/05/2026 07:42

May 14 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2026        Mar 31, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            916 mln              1.15             7.20     
                 (-20.4 pct)         (-16.5 pct)      (+12.5 pct) 
  Operating      loss 98 mln           44 mln           500 mln   
                                     (-79.5 pct)      (+8.9 pct)  
  Recurring      loss 93 mln           11 mln           520 mln   
                                     (-95.1 pct)      (+7.7 pct)  
  Net            loss 95 mln           292 mln          550 mln   
                                     (-38.1 pct)      (-40.4 pct) 
  EPS           loss 1.89 yen         5.83 yen         10.95 yen  
  Ann Div                             3.30 yen         3.50 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             3.30 yen         3.50 yen   
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T